Image
Image

mRNA Development
and Manufacturing

GMP mRNA drug substance manufacturing from sequence to commercial-scale supply, built on a dedicated nucleic acid platform with integrated in-house pDNA template supply, LNP encapsulation, and a direct pathway to sterile fill-finish.

mRNA Manufacturing Platform

Our dedicated Grade C (ISO 7) cGMP environment, physically separated from protein manufacturing suites and purpose-built for mRNA and pDNA manufacturing at clinical and commercial scale.
ImageImage

From Construct to Supply

mRNA Process Workflow

mRNA Sequence Design and Optimization

We work with client-supplied sequences or support construct optimization for translational performance, stability, and regulatory suitability.

pDNA Template Supply

Linearized pDNA template manufactured in-house within the same Nucleic Acid Suite, removing inter-site transfer and comparability requirements from the earliest stage of the manufacturing chain.

In Vitro Transcription (IVT) and Capping

IVT process optimized for high mRNA yield and transcriptional fidelity. Our platform is capping technology agnostic, with cap structure selection based on your program requirements and IP strategy.

Downstream Purification

Multi-step purification incorporating DNase treatment, dsRNA removal, tangential flow filtration for concentration and buffer exchange, and sterile final filtration, validated for dsRNA impurity levels, residual DNA template clearance, and potency specifications.
Image

mRNA Development
and Manufacturing

In vitro transcription optimized for mRNA yield, capping efficiency, and sequence fidelity.

RNA Modalities We Support

Image

Self-Amplifying RNA (saRNA)

Enhanced expression formats delivering therapeutic effect at lower administered doses, expanding the potential of RNA-based medicines.
Image

Non-Replicating mRNA

The established clinical format for vaccines, protein replacement therapies, and broader therapeutic applications, with a manufacturing platform designed for clinical and commercial scale.
Image

Circular RNA (circRNA)

Stability-enhanced RNA format offering extended expression duration, supporting programs requiring prolonged protein production from a single administration.
Image

Emerging RNA Formats

Support for emerging RNA therapeutic platforms, with our platform designed to adapt to novel formats as the field evolves.
3D molecular structure representing complex biologics and small molecule therapeutic development.

End-to-End Support for Your mRNA Program

Explore the development and manufacturing services that underpin every mRNA program at BioCina.

Process Development

01
Processes Designed to Grow With Your Program.
From bench to commercial scale, we develop bioprocesses built for reproducibility, regulatory confidence, and the long-term success of your therapy.
BioCina expert adjusting laboratory bioprocessing equipment for optimized process development and scale-up.

Analytical Development

02
Analytical Methods Built Around Your Program.
We develop, optimize and validate the analytical methods your program needs, from early characterization through to regulatory submission, with rigor at every step.
Laboratory team utilizing high-performance liquid chromatography for analytical development and biologics testing.

Tox Batches

03
Building Confidence Before You Scale.
We execute early-stage manufacturing runs generating the safety and process data your program needs to advance with clarity and confidence.
Specialist inspecting a stainless steel solution preparation tank for large-scale biologics and small molecule manufacturing.

Process Validation

04
Validation Built for Regulatory Confidence.
We execute rigorous process validation to the standards of the world's most demanding health authorities, giving your regulatory filing the strongest possible foundation.
Complex tubing and fluid management systems used for bioprocess validation in a CDMO laboratory.

Tech Transfer

05
A Seamless Transition From Your Facilities to Ours.
We manage every aspect of technology transfer with complete documentation, thorough risk assessment, and your team integrated at every critical milestone.
Image

cGMP Manufacturing

06
Where Programs Become Medicines.
We deliver GMP-compliant manufacturing across drug substance and drug product with the precision, consistency, and regulatory credibility every program deserves.
Image

    Did you know manufacturing in Australia could fund nearly half your program?

    Learn More
    3D scientific rendering of a lymphocyte cell showcasing surface receptors for advanced immunotherapy applications.

    Drug Substance Manufacturing Track Record

    0+ years
    of cGMP manufacturing experience
    0
    Critical Observations
    Image
    Image
    3
    BLA Submissions
    0+
    products manufactured
    Image

    Ready to Start Your mRNA Program?

    Every mRNA program starts with a conversation. Our team is ready to understand your requirements and find the right path forward.